Immage Biotherapeutics Corp (IMMG)

[GTINSPECTOR]

Here is QRC email. Last QRC recommendation ($EMMD) went from .20 to on its way to $4.00 today.






Dear Subscriber

If you are reading this, it’s because you subscribed to my newsletter and are looking to make significant gains in the market. You’re in luck because if you follow my recommendation today, you will have the edge.

The company I am going to tell you about is trading at around 30 cents and it could quickly pass 50-60 cents before the end of the day.

I am so convinced by the potential of this company that I would not be surprised to see it go from 30 cents to over $3 in just a matter of weeks to months.

My red hot stock pick for 2017 is a biotech company on the verge of greatness:


Company Name: imMage Biotherapeutics Corp

Trading Symbol: IMMG

Why is it that imMage Biotherapeutics Corp. (Symbol: IMMG) caught my attention when there are thousands of companies out there? Read on to find out.

IMMG is a biotech that is run by some of the most talented scientists in America. Together, they have more than 100 years of experience in the field and have more diplomas than we can count on our hands.

These brilliant American scientists have taken a targeted approach to solving a huge problem in America: Cancer.

While it may be true that we hear about a cure for cancer every other day, and practically every big company is working on one, the reality is that these efforts are not in vain.

Cancer IS curable and we (as a society) are on the verge of doing it.

The scientific community agrees that within our lifetime, this horrible disease will be cured thanks to massive advances in technology.

Think it’s crazy? Over the last 12 months a couple of people were cured of HIV using a novel gene therapy.

HIV is something long thought to be incurable, but now it’s looking very likely that we will have a worldwide roll out of a cure within the next few years.

Cancer kills 1 out of 4 people in our country and we have all been affected by it either directly or indirectly.

Who doesn't know someone who has succumbed to this illness? There is a way to fix this, and IMMG believes it has found the key.

IMMG scientists are targeting cancer cells using immunotherapy. They are able to identify the culprit-cells and destroy them without having to radiate the entire body (like is common with chemo).

This is an approach somewhat similar to what drugs like Humira and Remicade are doing, but for auto immune diseases (they target a specific type of cells only).

Both of these drugs are in the top 5 best-selling on the planet and have generate more than 32504866 dollars per week. They are used to treat all forms of auto immune diseases ranging from IBD diseases to arthritis and eczema.

The illnesses that these two drugs treat however only affect a very small fraction of the population as opposed to cancer which is unfortunately much more widespread, and despite that they are still making billions.

Can you imagine what a targeted Cancer therapy could do?

Apart from saving millions of lives and changing the world, the treatment would become the most profitable on the planet.

IMMG is targeting prostate and breast cancer to start with as these are the 2 most common types of cancer in the world today.

The company has already made serious headway over their last 10 years of research.

Late last year, the company announced that they have finally completed both in-vitro studies and animal trials which brings us very close to human trials, and even closer to a potential FDA approval.

And just last night IMMG announced some of the results of its animal studies, and they are blockbuster.

Most drugs never make it to invitro, let alone animal trials. IMMG has completed both and has literally just announced that their treatment made significant headway in curing cancer in mice.

I quote from their PR: “There was a significant increase in cell death of MAGE-A positive tumor cells compared to MAGE-A negative tumor cells.”

The rest of the PR can be found here: http://www.prnewswire.com/news-releases/immage-biotherapeutics-dna-immunotherapy-shows-high-efficacy-with-low-toxicology-results-300429805.html
Want to know what else is crazy? No one has even noticed this, except me. It boggles my mind that the share price is so low and I urge you to consider buying shares immediately before wall street finds out and sends the price sky rocketing.

IMMG is the type of company that could move to $20 dollars a share overnight under the right circumstances.

If that happens, you will feel like a genius for having had the foresight to buy 10,000 shares back when it was trading for pennies.

You can also visit their website at Immage Biotherapeutics' website: http://www.immagebio.com/
If you can pick up IMMG shares for anything less than 60 cents today, you could easily stand to gain over 1,500% if IMMG shares surge to $10 and beyond.

Put it simply: a $5,000 investment could potentially become close to $100,000 in just a matter of months.

One final word: if you are new to my newsletter, and perhaps have a healthy dose of skepticism, I invite you to simply put IMMG on your radar, sit back and relax and watch.

Keep your eyes peeled as IMMG goes on a massive bull run for the next 2 months – and at any point once you are convinced that this company is going places, make sure to jump right in to enjoy huge profits.

I am issuing an immediate trade alert for IMMG.

Yours truly,
Ian Phelps
Chief Editor for - QRCInvestmentGroup.com


Let's connect on social!

Copyright © 2017 QRC Investment Group, All rights reserved.